A 50-year-old man presented with progressive enlargement of a right medial canthal mass for 5 years. The patient subsequently noted epiphora of 6-month duration on the affected side. An anterior orbitotomy was performed, which uncovered a well-circumscribed mass in the lacrimal sac. Histologic sections of the mass revealed an angioleiomyoma. Following complete excision, the epiphora resolved and there is no evidence of tumor recurrence at 1 year of follow-up. To the best of our knowledge, this is the first report of an angioleiomyoma in the lacrimal sac.
Abstract:
A 50-year-old man presented with progressive enlargement of a right medial canthal mass for 5 years. The patient subsequently noted epiphora of 6-month duration on the affected side. An anterior orbitotomy was performed, which uncovered a well-circumscribed mass in the lacrimal sac. Histologic sections of the mass revealed an angioleiomyoma. Following complete excision, the epiphora resolved and there is no evidence of tumor recurrence at 1 year of follow-up. To the best of our knowledge, this is the first report of an angioleiomyoma in the lacrimal sac.
A ngioleiomyoma or vascular leiomyoma is a benign tumor composed of smooth muscle cells and vascular endothelium. 1 The majority of angioleiomyomas have a predilection for the lower extremities and typically presents as a solitary, painful, cutaneous mass. 2, 3 Approximately 8.5% to 10% of angioleiomyomas present in the head and neck region as a painless mass. 4 -6 In the orbit, there have been only 2 reported cases of angioleiomyoma. 7, 8 To date, there have been no cases of angioleiomyoma in the lacrimal outflow system. As far as we are aware, this is the first reported case of angioleiomyoma in the lacrimal sac.
CASE REPORT
A 50-year-old man was referred with right-sided epiphora of 6-month duration. Five years prior to presentation, the patient reported gradual enlargement of a "cyst" located at the right medial canthus. He had a history of an old orbital blowout fracture in the right orbit at the age of 13. The patient denied a history of pain, ulceration, redness, mucoid discharge, or hemorrhagic tearing. His medical history was significant for type II diabetes that was well controlled with metformin and glipizide. There was no prior history of surgery or tobacco use.
On clinical examination, visual acuity measured 20/20 OU. Pupillary examination was unremarkable and ocular ductions were full. Exophthalmometry revealed no asymmetry. Slit lamp examination and dilated fundoscopy were normal. External examination revealed a firm, dark-colored, nonmobile mass at the right medial canthus (Fig. A) . The lesion measured approximately 10 mm externally, and with palpation no discharge was noted. Lacrimal irrigation through the right inferior punctum revealed complete reflux through the superior punctum.
A curvilinear incision at the right medial canthus similar to an external dacryocystorhinostomy was performed. A subperiosteal dissection plane was created, and the lacrimal sac was reflected. The lacrimal sac was noticeably distended by the mass. A vertical incision was made in the lacrimal sac and a nodular mass was noted. Blunt dissection was used to completely excise the lesion (Fig. B) . Gross examination of the lesion revealed a red-brown, irregular mass measuring 1.0 cm ϫ 0.8 cm ϫ 0.5 cm (Fig. C) .
Histopathologic analysis of the lesion showed a confluence of vascular channels among dense bundles of muscle fibers (Fig. D, E) . A large thrombosis was present in a central vessel. Figure 1F shows immunostaining with smooth muscle actin that confirms the smooth muscle origin of the tumor, while HMB-45 immunostaining was negative (data not shown). Based on the histopathologic findings, the lesion was most consistent with angioleiomyoma.
After complete excision of the tumor, epiphora resolved and there was no evidence of recurrence at 1 year of follow-up.
DISCUSSION
Leiomyoma is an uncommon tumor of the orbit and has been well described in the literature. 9 Angioleiomyoma is a rare subset of leiomyoma and is distinguished by the predominance of endothelium-lined vascular channels among a background of smooth muscle. 1 In 1965, Wolter 8 reported the first case of orbital angioleiomyoma in a 41-year-old man with proptosis. In 1970, Henderson and Harrison 7 reported the second case of orbital angioleiomyoma in a 9-year-old girl with upward displacement of the right globe. Our case is the third report in the literature, but is the first report of an angioleiomyoma in the lacrimal sac causing epiphora.
Smooth muscle is relatively rare in the orbit. Given that angioleiomyoma is postulated to arise from the smooth muscle, possible tissues of origin include orbital blood vessels, pericytes, Müller muscle, or the capsulopalpebral muscle of Hes-sar. 9 It is easy to envisage the origin of the previously reported cases of angioleiomyoma in the orbit, but in our case, the identification of this tumor in the lacrimal sac cannot be easily explained.
In addition to serving as a conduit for tears through the nasolacrimal duct, the lacrimal sac is believed to have the ability to resorb tears. 10 The epithelium of the lacrimal sac is lined by an extensive microvillar network with a vascular plexus that is continuous with the cavernous body of the inferior turbinate. 11 In our case, the angioleiomyoma may have arisen from the smoothmuscle lining of this cavernous vasculature.
Angioleiomyoma is subdivided in 3 histopathologic subtypes: capillary or solid, cavernous, and venous. 1 The presence of a blood-filled central thrombus, exuberant proliferation of smooth muscle, and the well-circumscribed nature (Fig. D, E) classify this lesion as the cavernous subtype. Ferry and Kaltreider 12 reported a case of cavernous hemangioma in the lacrimal sac that demonstrated the typical gross and histopathologic features of this tumor. However, the diagnosis of angioleiomyoma in our case is solidified by the strong immunoreactivity with smooth muscle antigen (Fig. F) . In addition, this adnexal variant of angioleiomyoma stained negatively for HMB-45 compared with the positive immunoreactivity with this marker in the retroperitoneal and renal variants of angioleiomyomas. 1 Standard practice patterns for a medial canthal lesion of the lacrimal system are complete excision confirmed by histopathologic examination. Owing to the potential malignant nature of the patient's presentation with a medial canthal lesion, our goal was to excise the lesion without reconstruction by dacryocystorhinostomy or silicone stent placement. Interestingly, the lacrimal system remained patent after removal of the angioleiomyoma despite no intubation of the lacrimal system.
The prognosis of angioleiomyoma is excellent. The tumor is not radiosensitive and adjuvant external beam radiotherapy after incomplete excision is not advised. 13 Recurrence after incomplete excision has been reported, but in the absence of radiotherapy, there have been no reported cases of malignant transformation. 9 The treatment of choice remains complete surgical excision.
In summary, this is the first known case of angioleiomyoma in the lacrimal system. Complete surgical excision lead to resolution of all symptoms with no evidence of recurrence. Clinicians should be aware of angioleiomyoma when considering the differential diagnosis of medial canthal masses.
A, Clinical photograph of patient at presentation with a raised, bluish mass at the right medial canthus. B, Intraoperative photograph demonstrating the lesion in situ after opening of the lacrimal sac. C, Gross appearance of the lesion after complete excision. D, At low power, the smooth-muscle bundles are interposed between thin-walled cavernous vessels. Centrally, a large thrombosis is seen (hematoxylin-eosin, ϫ4). E, At medium power, the smooth-muscle and the adipose tissue components can be further visualized. F, Immunohistochemistry reveals marked reactivity to antibodies to smooth muscle in bundles of spindle cells. Myofibroblasts in the organizing thrombus also stain focally (antismooth muscle actin, ϫ40). 
Retained Silicone Sleeve as a Cause of Dacryocystorhinostomy Failure

F
ailure of dacryocystorhinostomy (DCR) surgery is most commonly due to cicatrizing closure of the rhinostomy or distal common canaliculus. Silicone intubation in DCR aims to prevent early membrane formation at the internal canalicular opening. One of the commonest complications related to canalicular silicone intubation is tube prolapse in the interpalpebral space, 1,2 and this may be prevented by stabilizing the tubes near the ostia with knots, 1,3 suture ties, 2 Ligaclips, 4 silicone sleeves such as the retinal-type Watzke sleeve, 2,5 or a combination of these. Inadvertently retained silicone tubing has been reported as a cause of persistent epiphora after DCR. 6, 7 However, the potential for retained tube-stabilizing sleeves to cause DCR failure following successful retrieval of the silicone tubes has not been reported previously.
We report 2 cases of DCR failure due to retained sleeves following successful tube removal, and highlight the importance of nasal endoscopy in the assessment of such patients.
CASE REPORTS Case 1.
A 35-year-old woman was referred with a 2-year history of bilateral epiphora, with no improvement following 3-snip punctoplasty. She was found to have bilateral nasolacrimal duct stenosis and a narrow left nasal passage because of septal deviation. She underwent bilateral sequential endoscopic DCR with bicanalicular intubation and stabilization of tubes with a size-10 silicone sleeve and Ligaclips. Left epiphora improved only 50% following retrieval of tubes, and 4 months postoperatively she was found to have delayed tear clearance and a delayed fluorescein endoscopic dye test. She was patent to syringing with no resistance or regurgitation, but found syringing uncomfortable. Because of nasal septal deviation, no view of the left internal ostium was possible. She underwent a septoplasty to allow endoscopic visualization of the left internal ostium and at the time a retained silicone sleeve was found (Fig. A) and removed (Fig. B) . Her epiphora subsequently improved.
Case 2.
An 80-year-old man presented with left-sided epiphora secondary to complete nasolacrimal duct obstruction. He underwent an uncomplicated left external DCR with bicanalicular silicone intubation stabilized with a silicone Watzke sleeve. His epiphora improved significantly, and tubes were removed under endoscopic guidance at 3 months. The internal ostium was not viewed at the time because of a narrow nasal passage and scar tissue. He presented 7 months postoperatively with recurrent epiphora, and was found to have a positive fluorescein dye retention test and syringing indicative of distal common canalicular stenosis. He subsequently underwent balloon dacryocystoplasty, and at the time of surgery was found to have a retained Watzke sleeve at the internal ostium that was removed along with scar tissue. Bicanalicular silicone tubes were inserted and stabilized with Ligaclips. His epiphora had completely resolved at 6-weeks follow-up.
DISCUSSION
Proximal stabilization of tubes near the ostia helps prevent lateral tube migration. Knots and silk ties are well-established means for securing tubes.
1-3 Ligaclips 4 and Watzke sleeves 2, 5 are more recent innovations for this purpose. Removal of tubes is generally undertaken at 1 month to 3 months after surgery, after the ostia has fully healed. Unless an endonasal endoscopic examination is carried out at this stage with visualization of the internal ostium, it is possible to leave behind a sleeve. The above cases emphasize the importance of confirming retrieval of all tube products and disputes the assumption that retained sleeves may simply become swallowed. The inadvertent retention of tube products or any foreign stabilization device near
